早产儿视网膜病变治疗新进展  

Current treatment progress on retinopathy of prematurity

作　　者：田丽丽[1,2] 任兵[2] 高晓唯[2] 

机构地区：[1]石河子大学医学院 [2]解放军第474医院全军眼科中心

出　　处：《国际眼科杂志》2014年第2期266-269,共4页International Eye Science

摘　　要：早产儿视网膜病变(retinopathy of prematurity,ROP)是早产儿和低体质量儿发生的一种视网膜血管增生性病变。近年来随着医疗护理水平不断提高,早产儿的存活率不断提高,ROP的发生率也明显增加。Retinopathy of prematurity （ROP） is a retinal vascular proliferative lesions which premature and low birth weight infants. The increasing in view of the rising numbers deliveries and improved neonatal care. disease of occurs in ncidence is of preterm Traditional modalities of treatment include cryotherapy and laser therapy, which are laborious and require special training. Hence, research is on the way to find novel treatment modalities used for early stage of the disease with the characteristics of easy operation, safety and efficacy. We reviewed the published and unpublished literature on newer methods of ROP management.

关 键 词：早产儿视网膜病变 抗血管内皮生长因子 胰岛 素样生长因子-1 促红细胞生成素 基因治疗 

分 类 号：R774.1[医药卫生—眼科]